Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma

Maya S, Kumar LG, Sarmento B, Sanoj RN, Menon D, Nair SV, et al. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. Carbohydr Polym. 2013;93(2):661–9. https://doi.org/10.1016/j.carbpol.2012.12.032. Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS, et al. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 2007;18(12):2009–14. https://doi.org/10.1093/annonc/mdm374. Nam JP, Park SC, Kim TH, Jang JY, Choi C, Jang MK, et al. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. Int J Pharm. 2013;457(1):124–35. https://doi.org/10.1016/j.ijpharm.2013.09.021. Gong XY, Yin YH, Huang ZJ, Lu B, Xu PH, Zheng H, et al. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan. Int J Pharm. 2012;436(1–2):240–7. https://doi.org/10.1016/j.ijpharm.2012.06.043. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73(8):2412–7. https://doi.org/10.1158/0008-5472.CAN-12-4561. Moosavian SA, Abnous K, Badiee A, Jaafari MR. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Colloids Surf, B. 2016;139:228–36. https://doi.org/10.1016/j.colsurfb.2015.12.009. Li C, Li H, Wang Q, Zhou M, Li M, Gong T, et al. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. J Control Release. 2017;246:133–41. https://doi.org/10.1016/j.jconrel.2016.12.027. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–91. https://doi.org/10.1038/nrd2803. Khan M, Ong ZY, Wiradharma N, Attia AB, Yang YY. Advanced materials for co-delivery of drugs and genes in cancer therapy. Adv Healthc Mater. 2012;1(4):373–92. https://doi.org/10.1002/adhm.201200109. Kim KS, Lee D, Song CG, Kang PM. Reactive oxygen species-activated nanomaterials as theranostic agents. Nanomedicine. 2015;10(17):2709–23. https://doi.org/10.2217/nnm.15.108. Li N, Cai H, Jiang L, Hu J, Bains A, Hu J, et al. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-pased nanoparticles for enhanced stability and anticancer efficacy. ACS Appl Mater Interfaces. 2017;9(8):6865–77. https://doi.org/10.1021/acsami.6b15505. Chen WL, Yang SD, Li F, Li JZ, Yuan ZQ, Zhu WJ, et al. Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency. Int J Pharm. 2016;511(2):728–40. https://doi.org/10.1016/j.ijpharm.2016.07.060. Singh B, Jiang T, Kim YK, Kang SK, Choi YJ, Cho CS. Release and cytokine production of bmpb from bmpb-loaded pH-sensitive and mucoadhesive thiolated eudragit microspheres. J Nanosci Nanotechnol. 2015;15(1):606–10. https://doi.org/10.1166/jnn.2015.8781. Yuan F, Wang S, Chen G, Tu K, Jiang H, Wang LQ. Novel chitosan-based pH-sensitive and disintegrable polyelectrolyte nanogels. Colloids Surf, B. 2014;122:194–201. https://doi.org/10.1016/j.colsurfb.2014.06.042. Chen WL, Li F, Tang Y, Yang SD, Li JZ, Yuan ZQ, et al. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Int J Nanomedicine. 2017;12:4241–56. https://doi.org/10.2147/IJN.S129748. Liu X, Xiang J, Zhu D, Jiang L, Zhou Z, Tang J, et al. Fusogenic reactive oxygen species triggered charge-reversal vector for effective gene delivery. Adv Mater. 2016;28(9):1743–52. https://doi.org/10.1002/adma.201504288. Luo CQ, Xing L, Cui PF, Qiao JB, He YJ, Chen BA, et al. Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy. Int J Nanomedicine. 2017;12:855–69. https://doi.org/10.2147/IJN.S122678. Zhang D, Wei Y, Chen K, Zhang X, Xu X, Shi Q, et al. Biocompatible reactive oxygen species (ROS)-responsive nanoparticles as superior drug delivery vehicles. Adv Healthc Mater. 2015;4(1):69–76. https://doi.org/10.1002/adhm.201400299. Wang F, Chen Y, Zhang D, Zhang Q, Zheng D, Hao L, et al. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles. Int J Nanomedicine. 2012;7:325–37. https://doi.org/10.2147/IJN.S27823. Guo H, Zhang D, Li C, Jia L, Liu G, Hao L, et al. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin. Int J Pharm. 2013;458(1):31–8. https://doi.org/10.1016/j.ijpharm.2013.10.020. Qi X, Qin J, Fan Y, Qin X, Jiang Y, Wu Z. Carboxymethyl chitosan-modified polyamidoamine dendrimer enables progressive drug targeting of tumors via pH-sensitive charge inversion. J Biomed Nanotechnol. 2016;12(4):667–78. https://doi.org/10.1166/jbn.2016.2206. Kuang Y, Balakrishnan K, Gandhi V, Peng X. Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs. J Am Chem Soc. 2011;133(48):19278–81. https://doi.org/10.1021/ja2073824. Broaders KE, Grandhe S, Frechet JM. A biocompatible oxidation-triggered carrier polymer with potential in therapeutics. J Am Chem Soc. 2011;133(4):756–8. https://doi.org/10.1021/ja110468v. Wang M, Sun S, Neufeld CI, Perez-Ramirez B, Xu Q. Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy. Angew Chem Int Ed Engl. 2014;53(49):13444–8. https://doi.org/10.1002/anie.201407234. Naito M, Ishii T, Matsumoto A, Miyata K, Miyahara Y, Kataoka K. A phenylboronate-functionalized polyion complex micelle for ATP-triggered release of siRNA. Angew Chem Int Ed Engl. 2012;51(43):10751–5. https://doi.org/10.1002/anie.201203360. Zhu R, Zhang CG, Liu Y, Yuan ZQ, Chen WL, Yang SD, et al. CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with alpha-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells. Sci Rep. 2015;5(1):17904. https://doi.org/10.1038/srep17904. Zhu S, Qian L, Hong M, Zhang L, Pei Y, Jiang Y. RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells. Adv Mater. 2011;23(12):H84–9. https://doi.org/10.1002/adma.201003944. Wu FL, Zhang J, Li W, Bian BX, Hong YD, Song ZY, et al. Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer. Oncotarget. 2017;8(40):67189–202. https://doi.org/10.18632/oncotarget.18066. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release. 2007;120(1–2):18–26. https://doi.org/10.1016/j.jconrel.2007.03.012. Chen ZN, Mi L, Xu J, Song F, Zhang Q, Zhang Z, et al. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys. 2006;65(2):435–44. https://doi.org/10.1016/j.ijrobp.2005.12.034. Sun H, Meng F, Cheng R, Deng C, Zhong Z. Reduction-responsive polymeric micelles and vesicles for triggered intracellular drug release. Antioxid Redox Signal. 2014;21(5):755–67. https://doi.org/10.1089/ars.2013.5733. Zhu WJ, Yang SD, Qu CX, Zhu QL, Chen WL, Li F, et al. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor. Int J Nanomedicine. 2017;12:3375–93. https://doi.org/10.2147/IJN.S126310. Zhu R. Study on the preparation and the liver cancer targeting of CD147 antibody-mediated α-Hederin chitosan nanoparticle [dissertation]. Soochow (China): Soochow University; 2014. Oh BM, Lee SJ, Cho HJ, Park YS, Kim JT, Yoon SR, et al. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer. Cell Death Dis. 2017;8(3):e2682. https://doi.org/10.1038/cddis.2017.446. Moon IJ, Kim KR, Chu HS, Kim SH, Chung WH, Cho YS, et al. N-acetylcysteine and N-nitroarginine methyl ester attenuate carboplatin-induced ototoxicity in dissociated spiral ganglion neuron cultures. Clin Exp Otorhinolaryngol. 2011;4(1):11–7. https://doi.org/10.3342/ceo.2011.4.1.11. Sun CY, Liu Y, Du JZ, Cao ZT, Xu CF, Wang J. Facile generation of tumor-pH-labile linkage-bridged block copolymers for chemotherapeutic delivery. Angew Chem Int Ed Engl. 2016;55(3):1010–4. https://doi.org/10.1002/anie.201509507. Zha Q, Wang X, Cheng X, Fu S, Yang G, Yao W, et al. Acid-degradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro. Mater Sci Eng, Proc Conf. 2017;78:246–57. https://doi.org/10.1016/j.msec.2017.04.098. Liu M, Min L, Zhu C, Rao Z, Liu L, Xu W, et al. Preparation, characterization and antioxidant activity of silk peptides grafted carboxymethyl chitosan. Int J Biol Macromol. 2017;104(Pt A):732–8. https://doi.org/10.1016/j.ijbiomac.2017.06.071. Yhee JY, Lee S, Kim K. Advances in targeting strategies for nanoparticles in cancer imaging and therapy. Nano. 2014;6(22):13383–90. https://doi.org/10.1039/c4nr04334k. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2011;63(3):131–5. https://doi.org/10.1016/j.addr.2010.03.011. He Y, Su Z, Xue L, Xu H, Zhang C. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. J Control Release. 2016;229:80–92. https://doi.org/10.1016/j.jconrel.2016.03.001. Hinrichs MJ, Dixit R. Antibody drug conjugates: nonclinical safety considerations. AAPS J. 2015;17(5):1055–64. https://doi.org/10.1208/s12248-015-9790-0. Yang SD, Zhu WJ, Zhu QL, Chen WL, Ren ZX, Li F, et al. Binary-copolymer system base on low-density lipoprotein-coupled N-succinyl chitosan lipoic acid micelles for co-delivery MDR1 siRNA and paclitaxel, enhances antitumor effects via reducing drug. J Biomed Mater Res, Part B. 2017;105(5):1114–25. https://doi.org/10.1002/jbm.b.33636.